Family medicine CME topics for 2026: what to focus on (and what can wait)

Editorial source check: October 8, 2026. This study-planning overview is not a clinical guideline or independent clinical review.

Family physicians don't get one guideline update a year. We get everyone's. In the last 15 months the blood pressure guideline was rewritten, two GLP-1 pills arrived, the FDA revised boxed warnings on an initial group of menopause hormone therapies, blood tests for Alzheimer's pathology reached primary care, and the federal vaccine schedule ended up in court. Meanwhile your 8:40 is a newborn, your 9:00 is a 92-year-old, and your 9:20 has three problems and a list.

For your 2026 study plan, start with these topics:

Below: what changed, where to read it, and what can wait until 2027.

Before choosing activities, compare your state CME requirements with your specialty board requirements. A useful study topic is not automatically an eligible credit activity.

What are the most important family medicine CME topics in 2026?

Why start with prevention and immunizations?

Because prevention is family medicine's home turf, and in 2026 the usual reference points moved.

USPSTF and HRSA: different documents and timelines

Start with the USPSTF's current recommendations, distinguishing final statements from drafts. The December 2024 cervical screening update remains labeled draft. Separately, HRSA announced updated guidelines on Jan. 5, 2026, including primary hrHPV testing as preferred for average-risk women ages 30 to 65 and an option for patient-collected samples. Associated coverage changes begin with plan years starting in 2027; they are not a new 2026 coverage entitlement.

Immunizations: know the documents, not the headlines

The neutral facts, per the Congressional Research Service (updated July 29, 2026), run like this. In June 2025 HHS replaced all 17 ACIP members. In January 2026 CDC issued a revised childhood schedule without an ACIP vote. Then on March 16, 2026, a federal court in American Academy of Pediatrics v. Kennedy stayed that schedule, 13 ACIP appointments and the committee's votes after June 11, 2025. At this editorial check, the CDC child schedule displays the July 2, 2025 addendum. Check that page and current court orders for subsequent changes. Meanwhile the AAP 2026 schedule and the AAFP 2026 child and adult schedules are published separately, and the AAFP released fall respiratory guidance on Sept. 2, 2026. Your study goal: know which document your practice, your state and your patients' plans reference, and be ready to explain the differences in plain English.

What changed in cardiometabolic care?

The 2025 AHA/ACC high blood pressure guideline

The new guideline (Aug. 14, 2025) keeps a goal below 130/80 mm Hg for adults with hypertension. It brings in the PREVENT calculator for 10- and 30-year risk, favors starting stage 2 treatment with two drugs, preferably in a single pill, widens screening for primary aldosteronism and frames early control as protecting the brain, not just the heart. Read it alongside the newer cardiology documents if you can.

ADA Standards of Care 2026

The 2026 revisions recommend CGM from diabetes onset for people on insulin or other therapies that can cause hypoglycemia. They also drop C-peptide and autoantibody prerequisites for pumps and automated insulin delivery in type 2 diabetes and add guidance on individualizing obesity medications in diabetes.

Obesity medicine, now in pill form

The FDA approved oral semaglutide 25 mg (Wegovy pill) on Dec. 22, 2025, and orforglipron (Foundayo), a non-peptide oral GLP-1 receptor agonist, on April 1, 2026. Injectable semaglutide also gained an accelerated approval for MASH with moderate to advanced fibrosis (Aug. 15, 2025). That makes MASLD risk stratification a natural companion topic. Worth studying: how each option differs, how to talk through long-term use, and which patients need a liver fibrosis assessment.

What's new in women's health across the lifespan?

• Prenatal care, tailored. ACOG Clinical Consensus No. 8 (2025) supports individualized visit schedules, telehealth and attention to unmet social needs for lower-risk pregnancies. Pair it with the 2025 USPSTF statements on syphilis screening in pregnancy and screening for intimate partner violence.
• Menopause. The FDA started removing cardiovascular, breast cancer and probable dementia language from boxed warnings on hormone therapy in November 2025 and approved the first relabeled products on Feb. 12, 2026. The endometrial cancer warning stays for systemic estrogen-alone products. The Menopause Society stresses that risk still depends on age and time since menopause. Expect patients to bring this up.
• Contraception. The 2024 CDC U.S. MEC and U.S. SPR remain the current editions. If you haven't read their chronic kidney disease and postpartum updates, this is your year.

What should behavioral health and substance use CME cover?

Recent changes affect behavioral health integration, telehealth prescribing and billing:

• Buprenorphine by telemedicine. The DEA/HHS buprenorphine telemedicine rule took effect Dec. 31, 2025. It allows an initial six-month supply via telemedicine, including audio-only, after a PDMP check.
• Broader telehealth prescribing. The DEA/HHS extension runs through Dec. 31, 2026, while permanent regulations are developed. Verify current federal and state requirements before prescribing; do not treat a proposed rule as effective law.
• Alcohol. The 2025 USPSTF draft reaffirms screening adults and offering brief counseling. Read the draft for its updated evidence on adolescents.
• Paying for integration. The 2026 Medicare Physician Fee Schedule added behavioral health integration and collaborative care add-on codes (G0568–G0570) to Advanced Primary Care Management. These billing changes are another topic to include in your practice-management reading.

How is cognitive care changing in primary care?

Primary care now has FDA-cleared blood tests for Alzheimer's pathology. Roche's Elecsys pTau181 was cleared in October 2025 to help rule out amyloid pathology in symptomatic adults 55 and older in primary care. Elecsys pTau217 received an FDA clearance decision on Aug. 19, 2026, announced by Roche on Aug. 24, with rule-in and rule-out cutoffs across primary and specialty care. The Alzheimer's Association guideline (July 2025) is written for specialty care. A primary care guideline on cognitive assessment tools is in development. Study how to sequence a structured cognitive assessment, a biomarker result and a referral, and how to explain an "intermediate" result to a worried family.

What's new in respiratory care and outpatient infections?

• COPD. GOLD 2026 adjusts the A/B/E criteria so that a single moderate exacerbation should prompt consideration of escalation. It adds a disease-activity section, separates initial from follow-up treatment, and updates case-finding and RSV/flu vaccination guidance.
• Asthma. GINA 2026 (May 2026) adds acute-asthma flowcharts for adults, for children 6 to 11 and for children 5 and younger in primary care and acute settings. It stresses that one exacerbation needing emergency care or oral steroids should trigger a treatment review.
• Stewardship. The IDSA 2025 complicated UTI guideline (July 2025) reclassifies UTIs by systemic signs. In patients who are improving, it favors early oral step-down and shorter courses.

How can the ABFM blueprint help you prioritize?

Since 2025, every ABFM exam, including the Family Medicine Certification Longitudinal Assessment (FMCLA), uses a blueprint built on clinical activities, not organ systems:

The FMCLA delivers 25 questions a quarter, with five minutes each and references allowed, until you reach 300 questions over three to four years. Under ABFM's 5-Year Cycle, you also need 60 certification points and 200 CME credits, at least half from Division I. Focused, regular reading on the topics above is a sensible way to keep your knowledge current between quarters.

Which family medicine updates can wait until 2027?

Skim now, read deeply when these land. Each date is the issuer's own target or deadline, and targets slip:

• ACC/AHA primary prevention guideline update and nonstatin therapy pathway: Q4 2026, per ACC's Clinical Policy in Progress page (updated June 15, 2026). Heart failure follows in 2027.
• AAFP 2027 immunization schedules: spring 2027, per AAFP. The court case may change the federal picture sooner.
• DEA telemedicine rules: the current federal extension runs through Dec. 31, 2026. Check DEA/HHS updates for a replacement or further extension rather than planning around an unconfirmed rulemaking date.
• USPSTF cervical cancer, breast cancer genetic risk and autism screening topics: in progress, no dates announced.
• Alzheimer's Association primary care cognitive assessment guideline: in development, no date.
• GOLD 2027 and ADA Standards 2027: both have come out around November and December in recent years, so save your deep COPD and diabetes reading for after they appear.

What does a three-day family medicine study plan look like?

Illustrative only. Choose your own topics and sources.

End each day with three lines: what I read, what surprised me, and what I'll do differently on Monday.

Where does Shift CME fit in?

Finding the guidelines is only part of the work. You also need time to read them and plan your learning around other commitments.

Shift CME lets you plan a self-directed conference at a destination you choose from our list. Every day of your dates, weekends included, is a 9:00 AM–2:00 PM local study day, with journal modules chosen for your specialty. For a family physician that might be prevention, obesity medicine and buprenorphine care. Time after 2:00 PM is free, which is handy if the family came along.

Shift keeps the records created through your participation. Your confirmation PDF is dated when you confirm and lists your program, venue and study days. A simple check-in from your phone confirms you're at your destination. After your last study day, we email your conference records and keep them together in Records. Knowledge checks and evaluations are optional unless required for the AMA CME credit you choose to claim.

These records are useful when you request a CME allowance, or for a self-employed physician's tax adviser. (This isn't tax advice. Ask a qualified tax professional.)

On credit, plainly: It depends on the session. A presentation or journal module offers AMA PRA Category 1 Credit™ only where its accredited provider offers a CME activity and supplies instructions for claiming it; then you claim it as that provider directs. That credit comes from the provider, not from Shift CME, and not every session offers it. Physicians may also self-claim AMA PRA Category 2 Credit™ for learning they judge meets the AMA's requirements, and your Shift CME records can support that claim. Nurse practitioners and physician assistants follow their own certifying bodies' rules: NCCPA lets PAs self-claim Category 2 CME, while AANPCB and ANCC require accredited contact hours, which Shift CME does not award. AAFP Prescribed credit and ABFM certification points come from activities those organizations approve. For ideas, see our Category 2 examples.

Family physicians should also know their own bodies' rules. The AAFP requires 150 credits per three-year cycle, at least 75 of them Prescribed, and counts informal self-learning as Professional Enrichment, an Elective category capped at 25 credits. ABFM lists medical journal reading under Division II, which can make up no more than half of your CME. Whether your reading qualifies is your call under those rules.

Want a look first? Explore a sample conference, and before December, run through our year-end CME checklist.

Frequently asked questions

Sources

1. CRS Insight IN12684: Changes to CDC Vaccine Recommendations in 2025 and 2026 (updated July 29, 2026)
2. AAFP: Immunization schedules and resources (2026)
3. AAFP: Fall immunization recommendations (Sept. 2, 2026)
4. Pediatrics: Recommended Childhood and Adolescent Immunization Schedule, United States, 2026 (AAP)
5. USPSTF: Home and recommendations
6. JAMA: USPSTF, Screening for Intimate Partner Violence and for Caregiver Abuse of Older or Vulnerable Adults (2025)
7. USPSTF: Draft recommendation, unhealthy alcohol use (Aug. 2025)
8. USPSTF: Cervical cancer screening (update in progress)
9. HRSA: Women's Preventive Services Guidelines, including the cervical screening update for plan years starting in 2027
10. ACC: New high blood pressure guideline (Aug. 14, 2025)
11. Circulation: 2025 AHA/ACC/Multisociety Guideline for High Blood Pressure in Adults
12. Diabetes Care: Summary of Revisions, Standards of Care in Diabetes—2026
13. Novo Nordisk: Wegovy pill FDA approval (Dec. 22, 2025)
14. FDA: First new molecular entity approved under National Priority Voucher program (orforglipron, April 1, 2026)
15. FDA: Approval of treatment for MASH (Aug. 15, 2025)
16. Obstetrics & Gynecology: ACOG Clinical Consensus No. 8, Tailored Prenatal Care Delivery (2025)
17. FDA: Labeling changes to menopausal hormone therapy products (Feb. 12, 2026)
18. The Menopause Society: Comments on FDA hormone therapy announcement (Nov. 10, 2025)
19. CDC: Contraceptive guidance for health care providers (U.S. MEC and U.S. SPR, 2024)
20. Federal Register: Expansion of Buprenorphine Treatment via Telemedicine Encounter
21. Federal Register: Fourth Temporary Extension of Telemedicine Flexibilities (Dec. 31, 2025)
22. CMS: CY 2026 Physician Fee Schedule final rule fact sheet
23. Roche: Elecsys pTau181 FDA clearance for primary care (Oct. 13, 2025)
24. Roche Diagnostics: Elecsys pTau217 FDA clearance (FDA decision Aug. 19, 2026)
25. Alzheimer's Association: Clinical practice guidelines and evidence
26. GOLD: 2026 Report and Key Changes summary (Nov. 10, 2025)
27. GINA: 2026 Strategy Report
28. IDSA: 2025 Guideline on Complicated Urinary Tract Infections
29. ACC: Clinical Policy in Progress (updated June 15, 2026)
30. ABFM: Family Medicine Exam Blueprint
31. ABFM: Longitudinal Assessment
32. ABFM: 5-Year Cycle
33. ABFM: Continuing Medical Education
34. AAFP: CME requirements for membership
35. AAFP: Types and definitions of CME credits for membership
36. AMA: What to know about the other kind of CME credit